All of these players come with a warning. We're not endorsing signing all of them, nor are we suggesting the Dodgers should continue investing in injured assets, but nobody on this list is at risk of missing the entire upcoming season.
Adam Cimber was just among the league's best relievers in 2021 and 2022. The Blue Jays ditched him last Friday and weren't willing to give him his projected $2.5 million for 2024 because of shoulder issues that knocked him out since June. An uncharacteristic first half was later determined to be a direct result of a shoulder impingement. He never returned after that diagnosis.
But now he's on the mend and, entering his age-33 season, could be the truest form of a low-risk, intriguing-reward signing. Cimber's sidearm delivery, when he's pitching to his potential, is a weapon any bullpen in the league would kill for.
He finished 2021 with a 2.26 ERA, 3.07 FIP and 1.07 WHIP in 71.2 innings with the Marlins and Blue Jays. In 2022, he led the league with 77 appearances and logged a 2.80 ERA, 3.47 FIP and 1.12 WHIP. The Dodgers could use him anywhere in their bullpen and wouldn't need to place high expectations on him, as they hopefully learned from doing so with the Reyes and Tommy Kahnle mistakes.